Page last updated: 2024-08-26

5-methylcytidine and Astrocytoma, Grade IV

5-methylcytidine has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Caputo, C; Coulter, JB; Green, JJ; Johnson, A; Khela, H; Lal, B; Laterra, J; Lopez-Bertoni, H; Lugo-Fagundo, M; Malloy, M; Rui, Y; Sall, S; Shudir, S	1

Other Studies

1 other study(ies) available for 5-methylcytidine and Astrocytoma, Grade IV

Article	Year
Sox2 induces glioblastoma cell stemness and tumor propagation by repressing TET2 and deregulating 5hmC and 5mC DNA modifications. Signal transduction and targeted therapy, 2022, 02-09, Volume: 7, Issue:1 Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Cytidine; Dioxygenases; DNA Methylation; DNA-Binding Proteins; DNA, Neoplasm; Female; Glioblastoma; Humans; Mice; Mice, Nude; Neoplasm Proteins; Neoplastic Stem Cells; SOXB1 Transcription Factors	2022

Article

Year

Sox2 induces glioblastoma cell stemness and tumor propagation by repressing TET2 and deregulating 5hmC and 5mC DNA modifications.

Signal transduction and targeted therapy, 2022, 02-09, Volume: 7, Issue:1

Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Cytidine; Dioxygenases; DNA Methylation; DNA-Binding Proteins; DNA, Neoplasm; Female; Glioblastoma; Humans; Mice; Mice, Nude; Neoplasm Proteins; Neoplastic Stem Cells; SOXB1 Transcription Factors

2022